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Objective: There is growing interest in the potential
benefits of public involvement (PI) in health and
social care research. However, there has been little
examination of values underpinning PI or how these
values might differ for different groups with an
interest in PI in the research process. We aimed to
explore areas of consensus and conflict around
normative, substantive and process-related values
underpinning PI.
Design: Mixed method, three-phase, modified Delphi
study, conducted as part of a larger multiphase
project.
Setting: The UK health and social care research
community.
Participants: Stakeholders in PI in research, defined
as: clinical and non-clinical academics, members of
the public, research managers, commissioners and
funders; identified via research networks, online
searches and a literature review.
Results: We identified high levels of consensus for
many normative, substantive and process-related
issues. However, there were also areas of conflict in
relation to issues of bias and representativeness, and
around whether the purpose of PI in health and social
care research is to bring about service change or
generate new knowledge. There were large differences
by group in the percentages endorsing the ethical
justification for PI and the argument that PI equalises
power imbalances. With regard to practical
implementation of PI, research support infrastructures
were reported as lacking. Participants reported
shortcomings in the uptake and practice of PI.
Embedding PI practice and evaluation in research
study designs was seen as fundamental to
strengthening the evidence base.
Conclusions: Our findings highlight the extent to
which PI is already embedded in research. However,
they also highlight a need for ‘best practice’ standards
to assist research teams to understand, implement
and evaluate PI. These findings have been used in
developing a Public Involvement Impact Assessment
Framework (PiiAF), which offers guidance to
researchers and members of the public involved in
the PI process.
INTRODUCTION
There is a growing interest internationally in
the potential benefits of public involvement
(PI) in health research.1–3 Within the UK,
the involvement of members of the public in
research is firmly established in health and
social care policy,4 and organisations includ-
ing, for example, the National Institute for
Strengths and limitations of this study
▪ Despite growing interest in the UK and inter-
nationally in the potential benefits of public
involvement (PI) in research, there has been little
examination of the values underpinning it, or of
how these values might be different for different
stakeholders. As part of a large study developing
guidance on how to assess the impact of PI in
research, we undertook a mixed method, modi-
fied Delphi study which has provided primary
evidence of areas of consensus and conflict
around the value systems underpinning PI in
research.
▪ Our mixed method, modified Delphi study
involved a heterogeneous panel of PI experts,
reflective of the range of key stakeholder groups
and was geographically diverse.
▪ ‘Consensus’ thresholds were determined in
advance of data collection, with two levels of
consensus defined.
▪ A limitation of our study was that panellists likely
were individuals with a strong commitment to
PI; we can therefore say nothing about the
values of those who choose not to engage with
the PI enterprise. A further limitation is that
response rates to the two-round survey were low
and that our conclusions are potentially biased.
However, a large percentage of the round 1
survey responders also completed the round 2
survey; and the quality of the data was high.
▪ Our findings not only provide important evidence
about value consensus, but also highlight a need
for ‘best practice’ standards to assist research
teams in the PI process.
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Health Research5 increasingly identify PI as a prerequis-
ite for funding.
There is a plethora of literature illuminating the
experiences of members of the public and professional
researchers, and the process of PI and its potential
impacts.6–9 However, while studies report on use of PI in
context of priority setting,10 11 the conduct of clinical
trials12 and the identification of treatment outcomes,13
there has been relatively little examination of the values
underpinning PI or about capturing and assessing the
impact of PI effectively.14–18 Possible reasons cited for
the limited number of studies evaluating the impact of
PI are that evaluation is too difficult and that PI is of
intrinsic value and as such needs no further justifica-
tion.16 19–21 The authors of the present article acknow-
ledge this latter perspective. However, we would argue
that the current lack of a research evidence base around
the impact of PI presents a challenge, since without
such an evidence base it is difficult to ensure integrity of
the PI endeavour, avoid potential adverse effects and
ensure that it is adequately resourced. The modified
Delphi study reported here was part of a larger Medical
Research Council funded study (G0902155/93948)
which aimed to review evidence on the values and
impacts associated with PI, develop guidance on how
these impacts can be assessed and contribute to the
development of good practice standards for PI. The
modified Delphi study utilised mixed methods to
explore areas of consensus and conflict underpinning
three over-arching value systems identified from a pre-
ceding literature review.22 These values relate to (1) nor-
mative perspectives on PI, which consider involvement
as an end in itself, for example, rights and empower-
ment; (2) substantive perspectives which consider the
consequences of PI, for example, quality and relevance
and (3) process-related values associated with good
involvement, for example, partnership and equality.
AIM AND OBJECTIVES OF THE DELPHI STUDY
The overall aim of the modified Delphi Study was to
explore areas of consensus and conflict around the nor-
mative, substantive and process-related values underpin-
ning PI in health and social care research. The specific
objectives were:
▸ To explore key issues identified from our literature
review with PI experts;
▸ To provide new knowledge about the views of differ-
ent stakeholders on PI;
▸ To contribute to the development of guidance on
how to assess the impact of PI in research.
METHODS
In this study, we defined PI as an active partnership
between members of the public and researchers in the
research process, rather than the use of people as the
‘subjects’ of research. The term ‘public’ has been used
as developed by the UK National Advisory Group
INVOLVE,23 and includes patients and potential
patients, carers and people who use health and social
care services. Within the study reported here, PI has
been achieved through the collaboration of academic
researchers with experience of working in the field of
PI, user investigators and the wider project’s Public
Advisory Group whose members contributed to all five
phases of the work. A mixed methods approach to data
collection was employed in a three-stage, modified
Delphi process:
▸ Three expert workshops (participant total n=42),
including members of the public, academic and user-
researchers, researcher/clinicians, research funders
and research managers were conducted to generate
qualitative data. The range of normative, substantive
and process-related values underpinning PI, identi-
fied in a previously conducted literature review,22
were discussed, to identify concepts to be explored at
round 1 (R1) and round 2 (R2) of the subsequent
modified Delphi survey;
▸ A pilot study to test the R1 survey questionnaire. As a
strategy to reduce attrition,24 25 careful attention was
paid to the content and layout of the invitation email,
the survey layout and the clarity of questions. Piloting
was conducted with academic (n=6) and user-
researchers (n=3) and members of our Patient
Advisory Group (n=2). Language, question type and
questionnaire formatting were edited in response to
participant feedback;
▸ A two-round modified Delphi survey was undertaken
between November 2011 and September 2012 to
explore areas of consensus and conflict around the
normative, substantive and process-related values
underpinning PI in health and social care research.
In this article, we describe the modified Delphi
process and report on the findings relating to the values
underpinning PI in health and social care research.
A subsequent article will report the survey findings in
relation to perceived PI barriers and facilitators, per-
ceived impacts of PI and potential approaches to its
evaluation.
A modified Delphi technique
The main premise of the Delphi technique is the
assumption that group opinion is more valid than indi-
vidual opinion. The technique offers a reliable data col-
lection method in circumstances where there is
uncertainty or a paucity of knowledge surrounding the
topic area under investigation.26–30 While the Delphi
technique has been used extensively within health and
social science research,31–38 criticism of the technique
includes the perception that it seeks to force consensus
and so is weakened by not allowing panellists to elabor-
ate on their views.32 In response to this criticism, the
current study used a modified Delphi technique which
did not force consensus; rather panellists were provided
with opportunities to elaborate on why they held the
views they expressed or endorsed,33 in order to allow us
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to try and tease out areas of conflict as well as areas of
consensus.
There are a number of key concepts and assumptions
which distinguish the basic Delphi technique from other
research methods. These include anonymity, multistage
iteration and controlled feedback, exploration of con-
sensus via statistical group response and the use of
experts.30 39 Each of these key characteristics was given
due consideration as a means of enhancing the validity
and reliability of the study design and the quality of
responses.28 40–43
Sampling and the use of ‘experts’
To reduce possible bias, our sampling strategy for panel
composition was reflective of the population subgroups
under investigation and geographically diverse.31 33 To
increase the reliability of the results, a large heteroge-
neous panel of ‘experts’, consisting of distinct stake-
holder groups was recruited.24 We defined ‘experts’ as a
group of informed individuals28 44 45—which, in this
instance, was knowledge and/or experience of PI in
health and social care research. Sampling was purposive.
We aimed to capture the various PI perspectives and
interests of members of the public, user, academic and
clinical researchers and research managers, directors,
commissioners and funders. Potential panellists were
identified in one of three ways: directly, through
research team members’ contacts and networks;
through online searches of open-access research infor-
mation and funding sites and via a review of literature in
the field of PI in health and social care research.
Anonymity
Complete anonymity could not be achieved as survey
panellists and their responses were known to some
members of the research team. However, anonymity
between panellists was guaranteed. Reactions to panel-
lists’ opinions, key arguments and levels of consensus for
each subgroup were fed back to panellists at R2 of the
modified Delphi survey; each opinion carried the same
weight and was afforded the same degree of importance
in the analysis. In this way, participant bias was elimi-
nated.33 This approach also enabled panellists to be
open and honest about their views on various issues as
well as providing them with an equal opportunity to
express an opinion without feeling pressured psycho-
logically to conform to the views of others.33
Quantitative data analysis
Determining how consensus cut-off points are reached
and understanding how they are derived are often prob-
lematic, as the reporting of such criteria is limited
within many published studies.29 To address this, we
sought statistical advice and defined specific criteria for
determining consensus thresholds a priori.
We took, as representing clear consensus, endorse-
ment or rejection of a statement by at least 60% of
respondents. However, attention was also paid to the
distribution of responses of the remaining 40%. Where
these responses clustered in one response option only,
consensus was not assumed and this item was further
explored in R2 of the survey. We took, as representing
critical consensus, endorsement or rejection of a state-
ment by at least 70% of respondents. An additional cri-
terion for critical consensus was that at least 55% of
responses either endorsed or rejected the extreme cat-
egories in the scales.
At R2, the results from the R1 survey were fed back to
panellists in the form of bar charts, textual summaries of
statistical data and summarised descriptions of qualita-
tive findings. Feedback included comparison of the
responses of the different subgroups for each item.
Particular attention was drawn to items demonstrating
either within-subgroup or between-subgroup dissent.
Items at R1 where between-subgroup differences were
greater than 10% were further explored at R2. Also
explored at R2 were any ‘unexpected’ (in the collective
view of the study team) endorsement/rejection of items
by the subgroups. We draw attention to these ‘unex-
pected’ responses in the findings section below.
Qualitative data analysis
In R1 and R2, to enable in-depth exploration of the
quantitative findings, panellists were provided with the
opportunity to make further comments as they saw fit,
through open questions. Thematic codes were identified
using Framework Analysis,46 a matrix-based method for
ordering and synthesising data. The analysis was con-
ducted by DS. Quality checking of the coding process
and reduction of coding bias were ensured by AJ, who
reviewed 10% of the qualitative data. First, data were
reviewed inductively to identify recurring themes and
concepts raised by panellists. These were coded and
formed the initial major and subthemes; additional
codes were then incorporated through an iterative
process involving DS and AJ. The thematic framework
was further refined before being applied systematically
to the whole dataset. This process facilitated the identifi-
cation of any inconsistencies in coding, which were sub-
sequently discussed and reconciled.
RESULTS
The iterative nature of the Delphi technique enabled R2
of the survey to be informed by the results of R1. For
this reason, the methods and results for both rounds are
discussed together.
Panellists
At R1, 740 (n=740) potential ‘expert’ panellists were
invited, via email, to participate in the online survey.
Non-responders were emailed two reminder letters as
appropriate, yielding a total response of 318 (n=318)
(response rate 43%). Responding panellists self-selected
themselves into one of five ‘stakeholder’ groups: clinical
academic (CA), (20%); non-CA (NCA), (28%); member
Snape D, Kirkham J, Preston J, et al. BMJ Open 2014;4:e004217. doi:10.1136/bmjopen-2013-004217 3
Open Access
group.bmj.com on November 27, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
of the public (MP), (17%); research manager or
funding/commissioning body employee (RM), (24%);
or occupying multiple roles (MR), (11%).
The characteristics of those who took part in R1 are
shown in table 1. Overall, the participants had high
levels of expertise, with most of them reporting having
at least 5 years of experience in research and three-
quarters having some responsibility for PI. However,
there were also differences in level of expertise,
members of the public being least likely to have lengthy
research experience or any specific PPI responsibilities.
In contrast, though fewer than half (n=134; 48%) of all
the panellists reported having had any formal training
relevant to PI, members of the public were far more
likely to have had such training (table 1), while aca-
demic researchers tended to emphasise ‘learned by
doing’.
The panellists reported being involved in a wide range
of research roles including, for example, drafting
research proposals and protocols (n=239; 86%); develop-
ing plain English summaries (n=238; 86%); sitting on
project advisory and steering groups (n=228; 82%); pre-
senting research findings (n=226; 82%) and being
involved in data collection (n=223; 815). The panellists
cited a number of practical learning opportunities
which underpinned their PI skills acquisition, including,
for example:
Good networking. [NCA, R1]
“…hard work building rapport and understanding of
the patients’ perspective, putting myself in their shoes.
[NCA, R1]
Support from others, learning alongside others, and
time. [CA, R1]
…so learning from mistakes and trying to listen to what
both the patients and the researchers need to make it a
meaningful experience. [MP, R1]
Various policy documents for engaging the public in
research on which we can rest our local framework and
priorities. [RF, R1]
All the panellists (n=318; response rate 43%) who sub-
mitted the R1 questionnaire were eligible to participate
in R2. Of the 318 responders, three electronically ‘opted
out’ of receiving further email communications. The R2
questionnaire was therefore emailed to 315 (n=315)
panellists. Up to two reminders were actioned as
required. A total of 231 (n=231) R2 survey responses
were received across the five stakeholder groups: CA,
(17%); NCA, (29%); MP, (18%); RM, (24%) and MR),
(12%), yielding a R2 response rate of 73% (of the 43%
who took part in R1).
Arguments related to the nature of knowledge
We asked our panellists to comment on what kinds of
knowledge they believed should inform health and
social care research. Responses at R1 (see figure 1)
revealed critical consensus across the different stake-
holder groups (over 90% strongly agreed/agreed) for
the substantive argument that members of the public
have unique knowledge and expertise that is comple-
mentary to that of professionals/clinicians and research-
ers, and should be valued equally.
A comment from one CA panellist illustrates this:
It is important not to conflate the complementary per-
spectives of clinical/health, social care professional
researchers versus methodologists. Both have important
knowledge and expertise to bring to the table in inform-
ing health and social care research, as do patients, their
informal carers and advocates and members of the
public…it is important that all of these perspectives are
regarded as equally important, rather than privileging
any one view over the others. [CA; R1]
Though it just failed to reach our definition of clear
consensus, there was broad support across the stake-
holder groups (58%) for the idea that while profes-
sionals/clinicians and researchers may also be service
users, they cannot themselves represent user issues
effectively. Since there was also some support across
stakeholder groups ( just over 50% strongly agreed/
agreed) for the idea that members of the research com-
munity and members of the public are likely to have
biased views about research, we explored this issue of
bias further in R2.
At R2, we asked panellists to comment on whether
they felt it mattered if different stakeholder groups held
views which others considered biased. Forty-three per








Clinical academic researcher 63 52 (82.5%) 52 (82.5%) 27 (42.9%)
Non-clinical academic researcher 88 70 (79.5%) 63 (71.6%) 27 (30.7%)
Member of the public 55 33 (60.0%) 27 (49.1%) 35 (63.6%)
Research manager/funder 76 53 (69.7%) 64 (84.2%) 31 (40.8%)
Dual role 34 30 (88.2%) 29 (85.3%) 14 (41.2%)
*Data taken from R1.
PI, public involvement; R1, round 1.
4 Snape D, Kirkham J, Preston J, et al. BMJ Open 2014;4:e004217. doi:10.1136/bmjopen-2013-004217
Open Access
group.bmj.com on November 27, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
cent said ‘yes’ they did feel it mattered, with a percent-
age range of 29–59% across stakeholder groups.
Individual stakeholder group responses are outlined in
table 2.
A common theme across panellists’ written comments
and one articulated by a panellist holding multiple roles
was that all research actors are biased to some degree,
holding different views based on knowledge and/or
experience.
All views will have a bias of some kind, but I think it is
more important that the view is ‘informed’. Bringing
together the different perspectives in an open, collabora-
tive way is one of the strengths of patient involvement,
not a weakness. [MR, R2].
Many panellists articulated that differences in perspec-
tive should not necessarily be viewed negatively; rather
they should be acknowledged as a ‘given’. Interestingly,
at R2, the issue of power (who holds the power to
enforce their viewpoint) was highlighted as more
important than the question of bias.
Following from this, in R2 process, values that involve
‘building relationships of trust between the different
stakeholder groups’ [NCA, R2] were frequently argued
to be key for managing difference and essential for
effective stakeholder partnerships and shared decision-
making.
Arguments related to the purposes of PI in health and
social care research
There was critical consensus (over 80% strongly agreed/
agreed) at R1, across all stakeholder groups, that
members of the public should be involved in publicly
funded research, and are entitled to say what and how
research is undertaken (see figure 2). There was also
critical consensus that members of the public should be
involved in research impacting on their own health or
on National Health Survey functioning and clear con-
sensus that they can influence how such research is used
(see figure 2). However, over 60% agreed/strongly
agreed that there are tensions between what members of
the public and researchers see as the purpose of
research and what constitutes good research.
At R2, we asked panellists to comment on whether
they believed these/such tensions within the arena of
health and social research could be resolved. Given that
tensions between the different stakeholder groups in the
PI enterprise have been highlighted elsewhere,47 a
somewhat unexpected finding from our data was critical
consensus (75%) that tension resolution was possible.
The percentage range across stakeholder groups was 67–
89%. Individual stakeholder group responses are out-
lined in table 3.
Also unexpected was that, though tension was seen as
an inevitable consequence of potential differences in
perspective and/or expectations, it was not necessarily
perceived as a negative issue. Rather it was seen by many
as a means to stimulate critical debate.
There should be tensions because that indicates passion;
but the differences need to be managed in an open and
transparent manner. [MP, R2]
Figure 1 What kinds of
knowledge should inform health
and social care research? Data
taken from Round 1.
Table 2 Does it matter if stakeholder groups hold views








39 23 (59%) 16 (41%)
Non-clinical academic
researcher
66 32 (48%) 34 (52%)
Member of the public 41 17 (41%) 24 (59%)
Research manager/funder 56 16 (29%) 40 (71%)
Dual role 27 10 (37%) 17 (63%)
*Data taken from R2.
R2, round 2.
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Tensions are a natural consequence of different stake-
holders having different priorities. To some extent the
debate they lead to could be regarded as conducive to
better decisions. [NCA, R2]
This is something to value, rather than to be concerned
about! As long as those considering the various perspec-
tives understand in advance that there may be differences
in opinion, then there aren’t ‘tensions’, just differences.
[CA, R2]
…if researchers, clinicians and members of the public
work together at the start of a trial, it will significantly
reduce these tensions. However I also think that you can
never entirely remove the tensions, and to some extent
this is a good thing as the element of struggle helps to
refine the research question. [MP, R2]
Once again, the need to promote values of effective
partnership working—including, for example, reci-
procity, communication, reflexivity and learning from
each other—was seen as a key to tension resolution over
time.
There was support in the panellists’ written responses
at R1 for the idea that PI training for members of the
public needed to not only include an overview of
research design and methods but should also involve
education about political and policy context(s) which
would lead to greater understanding of fundamental
research drivers and processes. It was articulated by
some panellists that training could also increase
empowerment of members of the public, promoting
and facilitating partnership working within the research
team. However, panel members also reflected that this
should not stop academic researchers from recognising
and valuing the experiential knowledge of members of
the public themselves.
Arguments relating to the why and the how of PI
There was overall critical consensus (over 70% strongly
agreed/agreed) that research is more ethical when
members of the public are involved at all stages of the
process. However, this statement was most strongly
endorsed by members of the public (94% strongly
agreed/agreed) and least endorsed by clinical (67%)
and non-clinical (59%) academics. There was critical con-
sensus across stakeholder groups (81% strongly agreed/
agreed) that involvement is empowering for members of
the public. Again, members of the public and those with
multiple roles were much more likely to agree (75%
strongly agreed/agreed) than were other groups (54%)
that PI equalises the power between them and profes-
sionals. Clear consensus was also reached (over 65%
agreed strongly/agreed) in relation to the statement that
PI was often a ‘tick the box’ exercise, with members of
the public more likely to express disappointment at the
lack of opportunity to influence the research process.
Some panellists (across all stakeholder groups) suggested
that involvement was still often seen as being tokenistic,
with ‘lip service’ only paid to the issue of PI.
There is the perception that it is an inconvenient tick
box exercise giving no added value and actually slowing
research process down. [CA, R2]
Until researchers recognise the importance and value of
public involvement, and how it can improve the quality
of their research, they are likely to give it low priority.
[CA, R2]
Figure 2 What are the purposes
of public involvement in health
and social care research? Data
taken from Round 1.











38 34 (89%) 4 (11%)
Non-clinical academic
researcher
66 44 (67%) 22 (33%)
Member of the public 41 35 (85%) 6 (15%)
Research manager/funder 54 37 (69%) 17 (31%)
Dual role 26 18 (69%) 8 (31%)
*Data taken from R2.
R2, round 2.
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While PI is no longer optional it can still feel like a hassle
for the academic community with gains that can seem
remote. That needs to change otherwise people will con-
tinue being tokenistic. [NCA, R2]
Panellists voiced a number of concerns about involv-
ing members of the public in the research process,
including the lack of funding to involve the public in
the early stages of research question and proposal devel-
opment. Time pressures related to grant applications
and project-specific time-lines were also highlighted as
problematic, including lack of time to take account for
public members’ illness and/or work commitments, the
lack of realistic timeframes for reviews and, not least, the
lack of time needed to develop and nurture research
team relationships.
At R1, a number of panellists expressed the view that a
‘fit-for-purpose model of PI, which reflected study and
social contexts, was a more appropriate way of assuring
effective PI than the various ‘levels of PI’ frameworks
proposed in the PI literature.48 Such frameworks were
not popular with panellists, who argued that the hier-
archical approach they embody to articulate different PI
levels was misleading and not necessarily an indication
of PI quality. The framework approach to PI was further
criticised for not addressing all the facets of involve-
ment, and as such having limited application and
becoming potentially a driver for tokenism. Interestingly,
INVOLVE49 have recently updated their guidance to
refer to ‘approaches’ rather than to ‘levels’ of involve-
ment and also recognises that different approaches to PI
might be used within the same project.
Following these responses, we asked panellists at R2
whether, in their opinion, they felt there were any cir-
cumstances where PI was inappropriate. There was crit-
ical consensus among the panellists that members of the
public could be involved in all/any type of research—
with the caveat that PI may be more challenging within
the field of basic science research. The following obser-
vation made by one panellist, a RM/funder, serves to
illustrate the potential for variation in the way members
of the public can be involved:
…hard to imagine a rationale for no involvement, but it
will vary from project to project. One argument is often
made that there shouldn’t be public involvement in pure
basic biomedical research and certainly the level of
involvement will be very different to that, say, of a clinical
trial. But there is still potential for involvement for
example in wider public debate/involvement about
evaluating this type of research and making policy deci-
sions about how much money to invest in this type of
research than more applied research. Some scientific
projects may require human samples and there is a role
for the public in the governance issues around this type
of research—or motivating others to donate tissue etc. I
have come across some aspects of clinical trials where,
for example, two different scales for measuring depres-
sion were compared—a very technical and limited bit of
work—with no room for influence from public involve-
ment—but this was one part of a much larger trial where
there was plenty of scope for involvement. So it may not
always be appropriate for public involvement to influence
the design and delivery of a project if it is very technical
—but there is likely to be value of involvement in other
aspects of the project around governance and funding
decisions and perhaps dissemination in informing people
that the research is going on—and explaining the impli-
cations of the research to a lay audience. [RM, Round 2]
DISCUSSION
This article reports findings from an online, modified
Delphi study involving a range of stakeholder groups to
explore normative, substantive and process-related
values underpinning PI in health and social care
research. This approach to gathering experts’ opinions
and suggestions without the need to bring them
together physically proved versatile and
resource-efficient. In this study, Delphi panellists’
responses were fairly evenly balanced across the various
stakeholder groups; and the response rate was, in our
view, acceptable given the ‘cold call’ approach.50–52
Allowing panellists an opportunity to comment on their
interpretation of the items and to express their views via
open-question feedback increased the reliability of the
study and improved the validity of the results.42
In the following discussion, we first consider key
themes emerging from the data in relation to the nor-
mative, substantive and process-related values underpin-
ning PI in health and social care research; second, we
highlight the potential limitations of our research
approach; and finally, we present our conclusions.
Key themes
Our findings suggest high levels of self-reported expert-
ise among members of the public involved in health and
social care research, regardless of little ‘formal’ educa-
tion and training in PI being reported. Panellists
reported that timely and appropriate training is required
by members of the public to support their involvement.
Similarly, panellists also articulated that other actors in
the research process require training in how to engage
and support members of the public in their research
roles. Support strategies suggested by panellists included,
for example, advice and mentoring schemes.
Overall, our R1 survey identified critical consensus
across stakeholder groups for many of the normative,
substantive and process-related issues explored. These
included that members of the public have an entitle-
ment to be involved in the research process, including
consideration of what research is undertaken and how it
is used, that different types of knowledge are important
and that members of the public have a unique knowl-
edge. These areas of consensus highlight the extent to
which PI is embedded in health and social care
research. However, there were also areas of conflict by
stakeholder group, for example, there was wide variation
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in the percentages endorsing the normative position
that research is more ethical where there is PI through-
out. Although ethical concerns are paramount in the
context of health and social care research, it is interest-
ing to note that the two stakeholder groups least likely
to endorse the importance of PI to ensure that research
probity were CA and NCA. There was also disagreement
about the extent to which PI was seen as equalising
power between the public and professionals, and about
the substantive issues around potential stakeholder
group bias and representativeness. These concerns
about the lack of representativeness of members of the
public who participate in PI in research initiatives have
preoccupied the PI community for some considerable
time53 54 and it has been argued that lack of clarity
about these concepts has led to PI being devalued.53
That it remains a focus of concern to our panellists high-
lights the need for a more sustained debate around the
nature of ‘representativeness’ and about implementing
involvement that is meaningful and appropriate.
Most health and social care research areas, including
preclinical, were deemed appropriate for PI, with many
panellists articulating their views about how and when it
might be feasible to introduce and evaluate involvement.
This reflects recent changes in commitment by the UK
funding bodies in incorporating PI across all research
designs and at all stages of the research process.5
Assessments about the appropriateness of PI need to be
viewed within the overall opportunities for members of
the public to influence project-specific agendas. A
recent review of case studies conducted by Boote et al47
highlighted potential tensions between different stake-
holder groups involved in PI. However, in our study, the
potential for tension was articulated as an inevitable con-
sequence of collaborative working; individuals’ agendas
can be different when designing research studies. The
acknowledgement and management of this standpoint
was deemed essential in reconciling potential stake-
holder difference. By promoting values of effective part-
nership, including, for example, communication,
reflexivity and learning from each other, research rela-
tionships can develop over time, and tension can lessen
as individuals work towards a common goal. The recog-
nition that tensions are inevitable and can be used pro-
ductively through questioning and discussion has also
been highlighted by Abma and Widdershoven.55
It is interesting to note that although panellists recog-
nised the normative debates around involving members
of the public in health and social care research and
acknowledged significant progress in doing so, they also
reported shortcomings in process and substantive-related
issues around the practice of PI in research, not least of
which is the need for quality standards where involve-
ment is embedded methodologically in research study
designs. Promoting and evaluating PI as ‘normalised’
research practice was seen as a key in strengthening the
evidence base around PI, which in turn, it was argued,
would reduce the practice of tokenism.
Delphi study limitations
In this study, we chose to adopt a modified Delphi
approach for data collection. This involved the use of
fixed choice and open questions in order to try to maxi-
mise our understanding of the issues under consider-
ation. As with all survey approaches, there are inevitably
limitations to the depth of the data obtained; and it
could be important to follow-up key issues using more
in-depth approaches, which would allow for more
detailed exploration of less well understood and articu-
lated issues.
Although Delphi techniques vary, face-to-face contact
with participants at R1 has been found useful in increas-
ing the response rate.28 However, due to the size of our
sample, many of the panellists were targeted ‘cold’
without any prior notice. This approach may have had
an impact on our response rate at R1. The use of remin-
ders is generally endorsed in texts on survey methods,56
and in line with Peterson et al,57 two reminder cover
letters were emailed to non-responding participants at
R1 and R2 of the survey to stimulate additional
responses.
That our response rate to R1 was low was unsurprising
given our approach; however, it was encouraging that a
large percentage of responders to R1 subsequently com-
pleted R2. The Delphi technique requires continued
commitment from participants throughout the data col-
lection process. Consideration must be given to the fact
that individual time constraints and lack of familiarity
with the Delphi technique may have prevented some
participants from being able to make such a commit-
ment. Nonetheless, the quality of the responses provided
made clear that those who did take part were firmly
committed to offering us detailed and extremely
thoughtful answers to our questions.
It could be argued that another potential limitation
relates to the representativeness of our panellists—
though as discussed above, the issue of what ‘representa-
tiveness’ involves in the context of PI remains a thorny
one. Under half of those we approached participated in
R1 of the study, and this proportion was further reduced
at R2. Since those who opted in to the survey self-
selected the stakeholder group with which they aligned
themselves, we have no information about the groupings
of those who opted out. We also have no information
about other characteristics of interest for which we col-
lected information from participants, for example, years
of involvement in PI or extent of training in PI. We are
therefore unable to comment meaningfully on the rep-
resentativeness or otherwise of the study population. As
previously clarified, we purposively set out to recruit PI
experts to our study; it is likely, therefore, that those
opting to take part were individuals with a particularly
strong commitment to PI in research, who were there-
fore keen to endorse its validity. Conversely, our study
may have failed to capture the views of people with
experience, but not the strong commitment to or opi-
nions about PI. Our findings may therefore offer an
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overly optimistic picture. This needs to be borne in
mind when interpreting the findings.
CONCLUSIONS
This study has identified a number of key issues around
PI implementation, in relation to the different weight-
ings given by different stakeholder groups to the values
around PI, and the resultant potential for conflict. This
study serves as one of the few attempts to empirically
gauge the views of key stakeholders on these issues. The
findings suggest that there is not only a large degree of
consensus across many of these issues, but also a healthy
level of debate in some important areas. While acknow-
ledging the problem of representativeness of our panel-
lists, we feel that this Delphi survey provides us with
important insight into the views of this group of PI
experts.
Our findings also support the conclusion of Boote
et al58 that there is a need for best practice standards
regarding PI, which research teams can follow when
seeking to involve members of the public in the research
process. The aim of the wider MRC research within
which this Delphi study sits was to develop and pilot
guidance to support assessment of the impacts of PI and
to produce draft of the best practice standards. Findings
from our modified Delphi study about commonly held
PI values and about assessment of PI impacts (the latter
is the subject of a separate article) have contributed to
this wider work by identifying areas where conflict is
likely to arise and suggesting ways such conflict can be
negotiated so the PI agenda can move forward
meaningfully.
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